NEUROBO PHARMACEUTICALS INC's ticker is NRBO and the CUSIP is 64132R107. A total of 26 filers reported holding NEUROBO PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $45,000 | -86.6% | 93,376 | -75.0% | 0.03% | -38.0% |
| Q1 2022 | $337,000 | -60.9% | 373,111 | -47.2% | 0.05% | -60.0% |
| Q4 2021 | $862,000 | +15.2% | 706,946 | +396.5% | 0.12% | -12.6% |
| Q4 2020 | $748,000 | -27.1% | 142,400 | -22.0% | 0.14% | -6.5% |
| Q3 2020 | $1,026,000 | -45.2% | 182,543 | -21.5% | 0.15% | -59.3% |
| Q2 2020 | $1,872,000 | – | 232,547 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 182,543 | $1,026,000 | 0.15% |
| Hayden Royal, LLC | 22,682 | $127,000 | 0.07% |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 6,454 | $36,000 | 0.00% |
| UBS Group AG | 1,913 | $11,000 | 0.00% |
| AMERICAN INTERNATIONAL GROUP, INC. | 2,559 | $14,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 2,012 | $11,000 | 0.00% |
| Russell Investments Group, Ltd. | 28,597 | $160,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,337 | $7,000 | 0.00% |
| NORTHERN TRUST CORP | 85,444 | $479,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |